Showing 1 - 19 results of 19 for search 'Yuanquan Yang', query time: 0.05s
Refine Results
-
1
-
2
-
3
Emerging Immunotherapy Approaches for Treating Prostate Cancer by Lingbin Meng, Yuanquan Yang, Amir Mortazavi, Jingsong Zhang
Published 2023-09-01
Article -
4
Impact of metakaolin on hydration properties of magnesium phosphate cement by Runqing Liu, Wei Wang, Yunpeng Cui, Yuanquan Yang
Published 2024-07-01
Article -
5
-
6
-
7
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report by Kai Johnson, Majd Issa, Anish Parikh, Paul Monk, Ming Yin, Amir Mortazavi, Yuanquan Yang
Published 2021-04-01
Article -
8
168 Associations of high toll-like receptor 3 gene expression and favorable anti-tumor immune microenvironment in metastatic clear cell renal cell carcinoma treated with immune che... by Zihai Li, Yuanquan Yang, Amir Mortazavi, Mingjia Li, Daniel Spakowicz, Komal Das, Jayajit Das, Giuseppe Giuliani, Anil Parwani
Published 2023-11-01Article -
9
-
10
TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop. by Yuanquan Yang, Zheng Wang, Hua Yang, Lingyan Wang, Stephanie R Gillespie, J Mario Wolosin, Audrey M Bernstein, Peter S Reinach
Published 2013-01-01
Article -
11
-
12
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therap... by Dixita M. Patel, Ruba Mateen, Noor Qaddour, Alessandra Carrillo, Claire Verschraegen, Yuanquan Yang, Zihai Li, Debasish Sundi, Amir Mortazavi, Katharine A. Collier
Published 2024-01-01
Article -
13
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma by Christopher Kwok, Adam Khorasanchi, Sarah P. Psutka, Megan Hinkley, Shawn Dason, Debasish Sundi, Yuanquan Yang, Yajing Yang, Claire Verschraegen, Evan E. Gross, Delaney Orcutt, Ming Yin
Published 2023-07-01
Article -
14
662 Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma by Rohit Jain, Yuanquan Yang, Amir Mortazavi, Jingsong Zhang, Jasreman Dhillon, Youngchul Kim, Wenyi Fan, Guru P Sonpavde, Juskaran Chadha, Monica Chatwal, Sarah Raymond, Erika Saunders, Trey Poehlman
Published 2023-11-01Article -
15
Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma by Yuanquan Yang, Sarah P. Psutka, Anish B. Parikh, Mingjia Li, Katharine Collier, Abdul Miah, Sherry V. Mori, Megan Hinkley, Scott S. Tykodi, Evan Hall, John A. Thompson, Ming Yin
Published 2022-08-01
Article -
16
-
17
Sex-biased adaptive immune regulation in cancer development and therapy by Johanna M. Schafer, Tong Xiao, Hyunwoo Kwon, Katharine Collier, Yuzhou Chang, Hany Abdel-Hafiz, Chelsea Bolyard, Dongjun Chung, Yuanquan Yang, Debasish Sundi, Qin Ma, Dan Theodorescu, Xue Li, Zihai Li
Published 2022-08-01
Article -
18
The Genomic Landscape of Urothelial Carcinoma with High and Low <i>ERBB2</i> Expression by Agreen Hadadi, Harris B. Krause, Andrew Elliott, Jacqueline T. Brown, Bassel Nazha, Lara R. Harik, Bradley C. Carthon, Benjamin Miron, Chadi Nabhan, Pedro C. Barata, Mohamed Saleh, Yuanquan Yang, Rana R. McKay, Mehmet A. Bilen
Published 2023-12-01
Article -
19
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial by Likun Zhou, Rui Liu, Dingzhi Huang, Hongli Li, Tao Ning, Le Zhang, Shaohua Ge, Ming Bai, Xia Wang, Yuchong Yang, XinYi Wang, Xingyun Chen, Zhiying Gao, Laizhi Luo, Yuanquan Yang, Xi Wu, Ting Deng, Yi Ba
Published 2021-11-01
Article